|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1998-7-1
|
|
pubmed:abstractText |
A growing body of data suggests that local control in nasopharyngeal cancer (NPC) is related to the radiation dose administered. We conducted a single-institution study of high-dose radiotherapy (RT), which incorporated high-dose-rate (HDR) brachytherapy (BT). These results were analyzed together with data obtained from controls who did not receive BT.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2213-20
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9626223-Adult,
pubmed-meshheading:9626223-Brachytherapy,
pubmed-meshheading:9626223-Carcinoma,
pubmed-meshheading:9626223-Combined Modality Therapy,
pubmed-meshheading:9626223-Dose Fractionation,
pubmed-meshheading:9626223-Dose-Response Relationship, Radiation,
pubmed-meshheading:9626223-Female,
pubmed-meshheading:9626223-Humans,
pubmed-meshheading:9626223-Male,
pubmed-meshheading:9626223-Middle Aged,
pubmed-meshheading:9626223-Multivariate Analysis,
pubmed-meshheading:9626223-Nasopharyngeal Neoplasms,
pubmed-meshheading:9626223-Survival Rate,
pubmed-meshheading:9626223-Treatment Outcome
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Fractionated high-dose-rate brachytherapy in primary carcinoma of the nasopharynx.
|
|
pubmed:affiliation |
Department of Radiation Oncology, University Hospital Rotterdam, Daniel den Hoed Cancer Center, The Netherlands. levendag@rtdh.azr.nl
|
|
pubmed:publicationType |
Journal Article
|
